Association of circulating branched-chain amino acids with risk of moyamoya disease

Association of circulating branched-chain amino acids with risk of moyamoya disease

ObjectiveBranched-Chain Amino Acids (BCAAs) has been identified as a risk factor for circulatory disease. Nevertheless, the effects and mechanisms of BCAAs on the risk of moyamoya disease (MMD) remain unrecognized. Hence, we aimed to elucidate the association between circulating BCAAs and the risk o...

Full description

Bibliographic Details
Main Authors:	Chaofan Zeng, Peicong Ge, Chenglong Liu, Xiaofan Yu, Yuanren Zhai, Wei Liu, Qiheng He, Junsheng Li, Xingju Liu, Jia Wang, Xun Ye, Qian Zhang, Rong Wang, Yan Zhang, Jizong Zhao, Dong Zhang
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2022-09-01
Series:	Frontiers in Nutrition
Subjects:	moyamoya disease branched-chain amino acids (BCAAs) metabolites biomarkers risk factors
Online Access:	https://www.frontiersin.org/articles/10.3389/fnut.2022.994286/full

Similar Items

Association between methionine sulfoxide and risk of moyamoya disease
by: Junsheng Li, et al.
Published: (2023-04-01)

Correlation of Serum N-Acetylneuraminic Acid with the Risk of Moyamoya Disease
by: Chenglong Liu, et al.
Published: (2023-06-01)

Gut microbiota in adults with moyamoya disease: characteristics and biomarker identification
by: Xiaofan Yu, et al.
Published: (2023-10-01)

Plasma urea cycle metabolite levels and the risk of moyamoya disease
by: Xiaofan Yu, et al.
Published: (2023-07-01)

Association between systemic immune-inflammatory markers and the risk of moyamoya disease: a case-control study
by: Wei Liu, et al.
Published: (2023-12-01)

Hyperhomocysteinemia Is a Predictor for Poor Postoperative Angiogenesis in Adult Patients With Moyamoya Disease
by: Qiheng He, et al.
Published: (2022-06-01)

Prognostic value of morphology and hemodynamics in moyamoya disease for long-term outcomes and disease progression
by: Long Ma, et al.
Published: (2024-11-01)

Circulating choline pathway nutrients and risk of moyamoya disease
by: Peicong Ge, et al.
Published: (2022-08-01)

High glutamine increases stroke risk by inducing the endothelial‐to‐mesenchymal transition in moyamoya disease
by: Qiheng He, et al.
Published: (2024-05-01)

Association Between p.R4810K Variant and Long-Term Clinical Outcome in Patients With Moyamoya Disease
by: Peicong Ge, et al.
Published: (2019-06-01)

Angiographic Outcomes of Direct and Combined Bypass Surgery in Moyamoya Disease
by: Peicong Ge, et al.
Published: (2019-12-01)

High-Dimensional Immune Profiling by Mass Cytometry Revealed the Circulating Immune Cell Landscape in Patients With Intracranial Aneurysm
by: Peicong Ge, et al.
Published: (2022-06-01)

Different subtypes of collateral vessels in hemorrhagic moyamoya disease with p.R4810K variant
by: Peicong Ge, et al.
Published: (2020-08-01)

Postoperative collateral formation after indirect bypass for hemorrhagic moyamoya disease
by: Peicong Ge, et al.
Published: (2020-01-01)

Systemic immune-inflammatory markers and long-term prognosis after revascularization in Moyamoya disease: a retrospective study
by: Shuang Wang, et al.
Published: (2024-09-01)

Circulating immune cell landscape and T‐cell abnormalities in patients with moyamoya disease
by: Peicong Ge, et al.
Published: (2024-04-01)

Nonalcoholic fatty liver disease is an independent risk factor for ischemic stroke after revascularization in patients with Moyamoya disease: a prospective cohort study
by: Bojian Zhang, et al.
Published: (2024-03-01)

Digital subtraction angiographic characteristics of progression of moyamoya disease 6 months prior to surgical revascularisation
by: Jia Wang, et al.
Published: (2020-03-01)

Single-cell atlas reveals different immune environments between stable and vulnerable atherosclerotic plaques
by: Peicong Ge, et al.
Published: (2023-01-01)

A Treatment Option for Symptomatic Chronic Complete Internal Carotid Artery Occlusion: Hybrid Surgery
by: Yunna Yang, et al.
Published: (2020-04-01)

Hypo-high density lipoproteinemia is a predictor for recurrent stroke during the long-term follow-up after revascularization in adult moyamoya disease
by: Xiaofan Yu, et al.
Published: (2022-07-01)

Cognitive Performance Profile in Pediatric Moyamoya Disease Patients and Its Relationship With Regional Cerebral Blood Perfusion
by: Jiaxi Li, et al.
Published: (2019-12-01)

Serum Creatine Levels as a Predictive Factor for Postoperative Cerebrovascular Events in Patients With Moyamoya Disease
by: Siqi Mou, et al.
Published: (2025-02-01)

Identification of heterogeneous subtypes and a prognostic model for gliomas based on mitochondrial dysfunction and oxidative stress-related genes
by: Junsheng Li, et al.
Published: (2023-06-01)

Risk factors for postoperative ischemic complications in pediatric moyamoya disease
by: Xiaofeng Deng, et al.
Published: (2021-06-01)

Multiomics and blood-based biomarkers of moyamoya disease: protocol of Moyamoya Omics Atlas (MOYAOMICS)
by: Peicong Ge, et al.
Published: (2024-02-01)

Crosstalk between CD180-overexpression macrophages and glioma cells worsens patient survival through malignant phenotype promotion and immunosuppressive regulation
by: Wen Wang, et al.
Published: (2024-12-01)

Analysis of the role of perfusion parameters in predicting rupture of brain arteriovenous malformations: a multi-center study
by: Yue Guo, et al.
Published: (2024-10-01)

Corrigendum: Development and validation of a model for predicting the risk of brain arteriovenous malformation rupture based on three-dimensional morphological features
by: Shaosen Zhang, et al.
Published: (2023-06-01)

Development and validation of a model for predicting the risk of brain arteriovenous malformation rupture based on three-dimensional morphological features
by: Shaosen Zhang, et al.
Published: (2022-11-01)

Single‐cell atlas of peripheral blood by CyTOF revealed peripheral blood immune cells metabolic alterations and neutrophil changes in intracranial aneurysm rupture
by: Xiaolong Ya, et al.
Published: (2024-08-01)

Metabolic alterations of peripheral blood immune cells and heterogeneity of neutrophil in intracranial aneurysms patients
by: Xiaolong Ya, et al.
Published: (2024-02-01)

Integrated Analysis to Reveal Heterogeneity of Tumor‐Associated Neutrophils in Glioma
by: Wen Wang, et al.
Published: (2025-03-01)

Chinese Cerebrovascular Neurosurgery Society and Chinese Interventional & Hybrid Operation Society, of Chinese Stroke Association Clinical Practice Guidelines for Management of Brain Arteriovenous Malformations in Eloquent Areas
by: Mingze Wang, et al.
Published: (2021-06-01)

Understanding external carotid artery collateralisation after cerebral revascularisation in moyamoya disease: insights from quantitative analysis
by: Jizong Zhao, et al.

Establishment and validation of a novel prognostic model for lower-grade glioma based on senescence-related genes
by: Junsheng Li, et al.
Published: (2022-10-01)

High <i>ECM2</i> Expression Predicts Poor Clinical Outcome and Promotes the Proliferation, Migration, and Invasiveness of Glioma
by: Junsheng Li, et al.
Published: (2023-05-01)

Reorganization of gray matter networks in patients with Moyamoya disease
by: Huan Zhu, et al.
Published: (2025-01-01)

Integrative analysis of TP73 profile prognostic significance in WHO grade II/III glioma
by: Yanming Chen, et al.
Published: (2021-07-01)

Association Between Ultrasound Parameters and History of Ischemic or Hemorrhagic Stroke in Patients With Moyamoya Disease
by: Shuai Zheng, et al.
Published: (2021-02-01)